Related Experiment Video
Updated: May 14, 2026
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Familial LCAT deficiency: from renal replacement to enzyme replacement
R M Stoekenbroek1, M A van den Bergh Weerman, G K Hovingh
1Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
The Netherlands Journal of Medicine
|February 16, 2013
Summary
Familial Lecithin-Cholesterol Acyltransferase (LCAT) deficiency (FLD) is a rare genetic lipid disorder. This study highlights variable progression to end-stage renal disease (ESRD) in affected siblings, emphasizing the need for new therapies.
Area of Science:
- Genetics
- Nephrology
- Biochemistry
Background:
- Familial Lecithin-Cholesterol Acyltransferase (LCAT) deficiency (FLD) is an inherited disorder of lipid metabolism.
- It is characterized by impaired cholesterol esterification, leading to lipid accumulation in tissues.
- FLD is a known cause of progressive kidney disease, often resulting in end-stage renal disease (ESRD).
Observation:
- This report details two brothers diagnosed with FLD.
- The siblings exhibited significant variability in the age of onset for ESRD.
- Kidney biopsies from both individuals showed combined tubular and glomerular damage.
Findings:
- The variable clinical presentation of ESRD in FLD siblings underscores the complex pathophysiology of the disease.
- Histopathological examination revealed significant renal pathology affecting both tubular and glomerular structures.
- Current therapeutic options for FLD are limited, with no causal treatments available.
Implications:
- Understanding the variable progression of FLD is crucial for patient management and prognosis.
- The findings suggest potential genetic or environmental factors influencing disease severity.
- Development of enzyme replacement therapy (ERT) offers a promising future treatment avenue for FLD patients.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...